Brief Profile

The Brief Profile summarizes the non-confidential data on substances as it is held in the databases of the European Chemicals Agency (ECHA), including data provided by third parties. The Brief Profile is automatically generated; note that it does not currently distinguish between harmonised classification and minimum classification; information requirements under different legislative frameworks may therefore not be fully up to date or complete. For accuracy reasons, substance manufacturers and imports have the responsibility to consult official sources, e.g. the electronic edition of the Official Journal of the European Union.
This Brief Profile is covered by the ECHA Legal Notice.

Substance Description

Substance identity

  • EC / List name:
  • IUPAC name: tridecalithium(1+) tetradecasodium 3-({4-[(4-amino-3-sulfophenyl)amino]-6-[methyl(2-sulfoethyl)amino]-1,3,5-triazin-2-yl}amino)-10-({4-[(10-amino-6,13-dichloro-4,11-disulfo-5,12-dioxa-7,14-diazapentacen-3-yl)amino]-6-[methyl(2-sulfoethyl)amino]-1,3,5-triazin-2-yl}amino)-6,13-dichloro-5,12-dioxa-7,14-diazapentacene-4,11-disulfonate 3-amino-10-({4,6-bis[(4-amino-3-sulfophenyl)amino]-1,3,5-triazin-2-yl}amino)-6,13-dichloro-5,12-dioxa-7,14-diazapentacene-4,11-disulfonate 3-amino-10-({4-[(10-amino-6,13-dichloro-4,11-disulfo-5,12-dioxa-7,14-diazapentacen-3-yl)amino]-6-[methyl(2-sulfoethyl)amino]-1,3,5-triazin-2-yl}amino)-6,13-dichloro-5,12-dioxa-7,14-diazapentacene-4,11-disulfonate 3-amino-10-({4-[(4-amino-3-sulfophenyl)amino]-6-[methyl(2-sulfoethyl)amino]-1,3,5-triazin-2-yl}amino)-6,13-dichloro-5,12-dioxa-7,14-diazapentacene-4,11-disulfonate 3-amino-10-[(4-{[4-({4-[(10-amino-6,13-dichloro-4,11-disulfo-5,12-dioxa-7,14-diazapentacen-3-yl)amino]-6-[methyl(2-sulfoethyl)amino]-1,3,5-triazin-2-yl}amino)-2-sulfophenyl]amino}-6-[methyl(2-sulfoethyl)amino]-1,3,5-triazin-2-yl)amino]-6,13-dichloro-5,12-dioxa-7,14-diazapentacene-4,11-disulfonate
  • Substance names and other identifiers
EC / List no.:
430-200-7
CAS no.:
-
Index number:
Molecular formula:
C213H126Cl16Li13N69Na14O97S27
SMILES:
[Li+].[Li+].[Li+].[Li+].[Li+].[Li+].[Li+].[Li+].[Li+].[Li+].[Li+].[Li+].[Li+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].CN(CCS([O-])(=O)=O)C1=NC(NC2=CC(=C(N)C=C2)S([O-])(=O)=O)=NC(NC2=C(C3=C(C=C2)N=C2C(Cl)=C4OC5=C(C=CC(N)=C5S([O-])(=O)=O)N=C4C(Cl)=C2O3)S([O-])(=O)=O)=N1.NC1=C(C=C(NC2=NC(NC3=C(C4=C(C=C3)N=C3C(Cl)=C5OC6=C(C=CC(N)=C6S([O-])(=O)=O)N=C5C(Cl)=C3O4)S([O-])(=O)=O)=NC(NC3=CC(=C(N)C=C3)S([O-])(=O)=O)=N2)C=C1)S([O-])(=O)=O.CN(CCS([O-])(=O)=O)C1=NC(NC2=C(C3=C(C=C2)N=C2C(Cl)=C4OC5=C(C=CC(N)=C5S([O-])(=O)=O)N=C4C(Cl)=C2O3)S([O-])(=O)=O)=NC(NC2=C(C3=C(C=C2)N=C2C(Cl)=C4OC5=C(C=CC(N)=C5S([O-])(=O)=O)N=C4C(Cl)=C2O3)S([O-])(=O)=O)=N1.CN(CCS([O-])(=O)=O)C1=NC(NC2=CC(=C(N)C=C2)S([O-])(=O)=O)=NC(NC2=C(C3=C(C=C2)N=C2C(Cl)=C4OC5=C(C=CC(NC6=NC(NC7=C(C8=C(C=C7)N=C7C(Cl)=C9OC%10=C(C=CC(N)=C%10S([O-])(=O)=O)N=C9C(Cl)=C7O8)S([O-])(=O)=O)=NC(=N6)N(C)CCS([O-])(=O)=O)=C5S([O-])(=O)=O)N=C4C(Cl)=C2O3)S([O-])(=O)=O)=N1.CN(CCS([O-])(=O)=O)C1=NC(NC2=CC(=C(NC3=NC(NC4=C(C5=C(C=C4)N=C4C(Cl)=C6OC7=C(C=CC(N)=C7S([O-])(=O)=O)N=C6C(Cl)=C4O5)S([O-])(=O)=O)=NC(=N3)N(C)CCS([O-])(=O)=O)C=C2)S([O-])(=O)=O)=NC(NC2=C(C3=C(C=C2)N=C2C(Cl)=C4OC5=C(C=CC(N)=C5S([O-])(=O)=O)N=C4C(Cl)=C2O3)S([O-])(=O)=O)=N1
InChI:
InChI=1S/2C54H40Cl4N18O25S7.C42H26Cl4N12O19S5.C33H23Cl2N11O14S4.C30H24Cl2N10O14S4.13Li.14Na/c1-75(13-15-102(77,78)79)53-71-49(69-51(73-53)67-26-11-9-24-39(47(26)107(92,93)94)100-43-31(57)33-41(29(55)35(43)64-24)98-37-22(62-33)7-4-19(59)45(37)105(86,87)88)61-18-3-6-21(28(17-18)104(83,84)85)66-50-70-52(74-54(72-50)76(2)14-16-103(80,81)82)68-27-12-10-25-40(48(27)108(95,96)97)101-44-32(58)34-42(30(56)36(44)65-25)99-38-23(63-34)8-5-20(60)46(38)106(89,90)91;1-75(13-15-102(77,78)79)53-71-49(61-18-3-4-19(59)28(17-18)104(83,84)85)69-50(72-53)66-25-10-7-23-38(46(25)106(89,90)91)100-43-31(57)36-44(32(58)35(43)64-23)101-40-24(65-36)9-12-27(48(40)108(95,96)97)68-52-70-51(73-54(74-52)76(2)14-16-103(80,81)82)67-26-11-8-22-39(47(26)107(92,93)94)99-42-30(56)33-41(29(55)34(42)63-22)98-37-21(62-33)6-5-20(60)45(37)105(86,87)88;1-58(10-11-78(59,60)61)42-56-40(53-18-8-6-16-30(38(18)81(68,69)70)76-34-22(45)24-32(20(43)26(34)51-16)74-28-14(49-24)4-2-12(47)36(28)79(62,63)64)55-41(57-42)54-19-9-7-17-31(39(19)82(71,72)73)77-35-23(46)25-33(21(44)27(35)52-17)75-29-15(50-25)5-3-13(48)37(29)80(65,66)67;34-21-24-28(22(35)23-27(21)59-25-16(41-23)6-5-15(38)29(25)63(53,54)55)60-26-17(42-24)7-8-18(30(26)64(56,57)58)43-33-45-31(39-11-1-3-13(36)19(9-11)61(47,48)49)44-32(46-33)40-12-2-4-14(37)20(10-12)62(50,51)52;1-42(8-9-57(43,44)45)30-40-28(35-11-2-3-12(33)17(10-11)58(46,47)48)39-29(41-30)38-16-7-6-15-23(27(16)60(52,53)54)56-25-19(32)20-24(18(31)21(25)37-15)55-22-14(36-20)5-4-13(34)26(22)59(49,50)51;;;;;;;;;;;;;;;;;;;;;;;;;;;/h3-12,17H,13-16,59-60H2,1-2H3,(H,77,78,79)(H,80,81,82)(H,83,84,85)(H,86,87,88)(H,89,90,91)(H,92,93,94)(H,95,96,97)(H2,61,67,69,71,73)(H2,66,68,70,72,74);3-12,17H,13-16,59-60H2,1-2H3,(H,77,78,79)(H,80,81,82)(H,83,84,85)(H,86,87,88)(H,89,90,91)(H,92,93,94)(H,95,96,97)(H2,61,66,69,71,72)(H2,67,68,70,73,74);2-9H,10-11,47-48H2,1H3,(H,59,60,61)(H,62,63,64)(H,65,66,67)(H,68,69,70)(H,71,72,73)(H2,53,54,55,56,57);1-10H,36-38H2,(H,47,48,49)(H,50,51,52)(H,53,54,55)(H,56,57,58)(H3,39,40,43,44,45,46);2-7,10H,8-9,33-34H2,1H3,(H,43,44,45)(H,46,47,48)(H,49,50,51)(H,52,53,54)(H2,35,38,39,40,41);;;;;;;;;;;;;;;;;;;;;;;;;;;/q;;;;;27*+1/p-27
Type of substance:
Multi constituent substance
Origin:
Organic
Registered compositions:
3
Of which contain:
0 impurities relevant for classification
0 additives relevant for classification
Substance Listed:
ELINCS (European LIst of Notified Chemical Substances) List

Hazard classification & labelling

Danger! According to the harmonised classification and labelling (ATP01) approved by the European Union, this substance causes serious eye damage and is harmful to aquatic life with long lasting effects.

Breakdown of all 38 C&L notifications submitted to ECHA

Eye Dam. 1 H318 Harmonised Classification
Aquatic Chronic 3 H412 Harmonised Classification
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%

https://www.echa.europa.eu/diss-blank-theme/images/cnl/graph/tick.png Harmonised Classification

https://www.echa.europa.eu/diss-blank-theme/images/cnl/graph/Reach.png REACH registration dossiers notifications

https://www.echa.europa.eu/diss-blank-theme/images/cnl/graph/CLP.png CLP notifications

Properties of concern

Regulatory context

Registration, Evaluation, Authorisation & Restriction of Chemicals (REACH)

Registration
Pre-registration:
Substance pre-registered under REACH.
Registration:
This substance has 2 active registrations under REACH, 1 Joint Submission(s) and 1 Individual Submission(s).
Please see Registrants/Suppliers details.
Evaluation
Dossier Evaluation:
Substance Evaluation:
Authorisation
Candidate List:
Annex XIV (Authorisation List):
Restriction
Annex XVII (Restriction List):

Persistent Organic Pollutants Regulation (POPs)

List of substances subject to the POPs Regulation:
List of substances proposed as POPs:

Classification Labelling & Packaging (CLP)

Harmonised C&L:
A European Union Harmonised Classification & Labelling has been assigned to this substance.
Seveso Annex I:
Notified C&L:
Classification & Labelling has been notified by industry to ECHA for this substance.

Biocidal Products Regulation (BPR)

Active Substance:
Biocidal Products:

Prior Informed Consent (PIC)

Annex I:
Annex V:

European Union Observatory for Nanomaterials (EUON)

EUON:

About this substance

This substance has not been registered under the REACH Regulation, therefore as yet ECHA has not received any data about this substance from registration dossiers.

This substance is used in articles, in formulation or re-packing, at industrial sites and in manufacturing.

ECHA has no public registered data indicating whether or in which chemical products the substance might be used.

ECHA has no public registered data on the routes by which this substance is most likely to be released to the environment.

ECHA has no public registered data on the use of this substance in activities or processes at the workplace.

Other release to the environment of this substance is likely to occur from: indoor use in long-life materials with low release rate (e.g. flooring, furniture, toys, construction materials, curtains, foot-wear, leather products, paper and cardboard products, electronic equipment).

This substance can be found in products with material based on: paper (e.g. tissues, feminine hygiene products, nappies, books, magazines, wallpaper).

ECHA has no public registered data indicating whether or in which chemical products the substance might be used.

ECHA has no public registered data on the types of manufacture using this substance.

ECHA has no public registered data on the use of this substance in activities or processes at the workplace.

ECHA has no public registered data on the routes by which this substance is most likely to be released to the environment.

This substance is used in the following products: paper chemicals and dyes.

This substance is used in the following activities or processes at workplace: closed batch processing in synthesis or formulation, mixing in open batch processes, transfer of chemicals at dedicated facilities and transfer of substance into small containers.

Release to the environment of this substance can occur from industrial use: formulation of mixtures.

This substance is used in the following products: paper chemicals and dyes.

This substance is used for the manufacture of: pulp, paper and paper products.

This substance is used in the following activities or processes at workplace: closed, continuous processes with occasional controlled exposure, mixing in open batch processes, transfer of chemicals at dedicated facilities and treatment of articles by dipping and pouring.

Release to the environment of this substance can occur from industrial use: in the production of articles.

This substance is used in the following activities or processes at workplace: closed batch processing in synthesis or formulation, transfer of chemicals at dedicated facilities and transfer of substance into small containers.

Release to the environment of this substance can occur from industrial use: manufacturing of the substance.

Precautions for using this substance have been recommended by its registrants under REACH, as follows:

Prevention statements

When handling this substance: avoid release to the environment; wear protective gloves and/or clothing, and eye and/or face protection as specified by manufacturer/supplier.

Response statements

In case of incident: If in eyes: rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do – continue rinsing.

Guidance on the safe use of the substance provided by manufacturers and importers of this substance.

Registrants/suppliers

  • Archroma France, SAS, Rue du Flottage 60350 Trosly-Breuil France
  • ARCHROMA IBÉRICA, S.L., ZAL-Prat c/Cal Coracero, 46-56 08820 El Prat de Llobregat Spain
  • Archroma France, SAS - OR, Rue du Flottage, BP 1 60350 Trosly-Breuil France

Substance names and other identifiers

BLUE HAS 2-192
REACH pre-registration
reaction mass of mono to tetra(lithium and/or sodium)3-amino-10-[4-(4-amino-3-sulfonatoanilino)-6-[methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2-ylamino]-6-13-dichlorobenzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate; mono to tetra(lithium and/or sodium)3-amino-10-[4,6-bis(4-amino-3-sulfonatoanilino)-1,3,5-triazin-2-ylamino]-6-13-dichlorobenzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate; mono to penta(lithium and/or sodium)10,10´-diamino-6,6',13,13´-tetrachloro-3,3'-[6-[methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2,4-diyldiimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate; mono to hepta(lithium and/or sodium)10-amino-6,6',13,13'-tetrachloro-10´[4-(4-amino-3-sulfonatoanilino)-[6-methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2,4-diimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate; mono to hepta(lithium and/or sodium)10,10'-diamino-6,6',3,3'[(2-sulfonato)-1,4-phenylenediiminobis[6-methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2,4-diyldiimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate
C&L Inventory
10,10'-diammino-6,6',3,3'-[(2-solfonato)-1,4-fenilendiimminobis[6-metil(2-solfonatoetil)ammino]-1,3,5-triazin-2,4-diildiimmino]bis[benzo[1,2-b:4,5-b']di[1,4]benzoxazina-4,11-disolfonato da mono a epta (litio e/o sodio) (it)
C&L Inventory
10,10´-diammino-6,6',13,13´-tetracloro-3,3'-[6-[metil(2-solfonatoetil)ammino]-1,3,5-triazin-2,4-diildiimmino]bis[benzo[1,2-b:4,5-b']di[1,4]benzoxazina-4,11-disolfonato da mono a penta (litio e/o sodio) (it)
C&L Inventory
10-ammino-6,6',13,13'-tetracloro-10´-[4-(4-ammino-3-solfonatoanilino)-[6-metil(2-solfonatoetil)ammino]-1,3,5-triazin-2,4-diimmino]bis[benzo[1,2-b:4,5-b']di[1,4]benzoxazina-4,11-disolfonato da mono a epta (litio e/o sodio) (it)
C&L Inventory
3-ammino-10-[4,6-bis(4-ammino-3-solfonatoanilino)-1,3,5-triazin-2-ilammino]-6,13-diclorobenzo[1,2-b:4,5-b']di[1,4]benzoxazina-4,11-disolfonato da mono a tetra (litio e/o sodio) (it)
C&L Inventory
6,6',13,13'-tetrakloro-3,3'-[6-[metil-(2-sulfonatoetil)amino]-1,3,5-triazin-2,4-diildiimino] bis[benzo[1,2-B:4,5-B']di[1,4]benzoksazin-4,11-disulfonat (hr)
C&L Inventory
6,6',3,3'[(2-sulfonato)-1,4-fenilendiiminobis[6-metil-(2-sulfonatoetil)amino]-1,3,5-triazin-2,4-diildiimino]bis[benzo[1,2-B:4,5-B']di[1,4] benzoksazin-4,11-disulfonat (hr)
C&L Inventory
[1,4]benzoksazin-4,11-disulfonat (hr)
C&L Inventory
[metil-(2-sulfonatoetil)amino]-1,3,5-triazin-2-ilamino]-6-13-diklorobenzo[1,2-B:4,5-B'] di[1,4]benzoksazin-4,11-disulfonat (hr)
C&L Inventory
amestec de mono până la tetra(litiu şi/sau sodiu)3-amino-10-[4-(4-amino-3-sulfonato-anilino)-6-[metil-(2-sulfonato-etil)amino]-1,3,5-triazin-2-ilamino]-6-13-diclor-benzo[1,2-B:4,5-B']di[1,4]benzoxazin-4,11-disulfonat; mono până la tetra(litiu şi/sau sodiu)3-amino-10-[4,6-bis(4-amino-3-sulfonato-anilino)-1,3,5-triazin-2-ilamino]-6-13-diclor-benzo[1,2-B:4,5-B']di[1,4]benzoxazin-4,11-disulfonat; mono până la penta(litiu şi/sau sodiu)10,10´-diamino-6,6',13,13´-tetraclor-3,3'-[6-[metil-(2-sulfonato-etil)amino]-1,3,5-triazin-2,4-diildi-imino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazin-4,11-disulfonat; mono până la hepta(litiu şi/sau sodiu)10-amino-6,6',13,13'-tetraclor-10´[4-(4-amino-3-sulfonato-anilino)-[6-metil-(2-sulfonato-etil)amino]-1,3,5-triazin-2,4-di-imino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazin-4,11-disulfonat; mono până la hepta(litiu şi/sau sodiu)10,10'-diamino-6,6',3,3'[(2-sulfonato)-1,4-fenilen-di-iminobis[6-metil-(2-sulfonato-etil)amino]-1,3,5-triazin-2,4-diildiimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazin-4,11-disulfonat (ro)
C&L Inventory
amino]-1,3,5-triazin-2,4-diimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoksazin-4,11-disulfonat (hr)
C&L Inventory
Blanding af: (da)
C&L Inventory
blanding av: mono til tetra(litium og/eller natrium)-3-amino-10-[4-(4-amino-3-sulfonatoanilino)-6-[metyl-(2-sulfonatoetyl)amino]-1,3,5-triazin-2-ylamino]-6-13-diklorbenzo[1,2-B:4,5-B']di[1,4]benzoksazin-4,11-disulfonat (no)
C&L Inventory
Blandning av mono-, di-, tri- och tetra(litium- och/eller natrium)3-amino-10-[4-(4-amino-3-sulfonatoanilino)-6-[metyl-(2-sulfonatoetyl)amino]-1,3,5-triazin-2-ylamino]-6-13-diklorobenso[1,2-B:4,5-B']di[1,4]bensoxazin-4,11-disulfonat; mono-, di-, tri- och tetra(litium- och/eller natrium)3-amino-10-[4,6-bis(4-amino-3-sulfonatoanilino)-1,3,5-triazin-2-ylamino]-6-13-diklorobenso[1,2-B:4,5-B']di[1,4]bensoxazin-4,11-disulfonat; mono-, di-, tri-, tetra- och penta(litium- och/eller natrium)10,10´-diamino-6,6',13,13´-tetrakloro-3,3'-[6-[metyl-(2-sulfonatoetyl)amino]-1,3,5-triazin-2,4-diyldiimino]bis[benso[1,2-B:4,5-B']di[1,4]bensoxazin-4,11-disulfonat; mono-, di-, tri-, tetra-, penta-, hexa- och hepta(litium- och/eller natrium)10-amino-6,6',13,13'-tetrakloro-10´[4-(4-amino-3-sulfonatoanilino)-[6-metyl-(2-sulfonatoetyl)amino]-1,3,5-triazin-2,4-diimino]bis[benso[1,2-B:4,5-B']di[1,4]bensoxazin-4,11-disulfonat; mono-, di-, tri-, tetra-, penta-, hexa- och hepta(litium- och/eller natrium)10,10'-diamino-6,6',3,3'[(2-sulfonato)-1,4-fenylendiiminobis[6-metyl-(2-sulfonatoetyl)amino]-1,3,5-triazin-2,4-diyldiimino]bis[benso[1,2-B:4,5-B']di[1,4]bensoxazin-4,11-disulfonat (sv)
C&L Inventory
järgmiste ainete segu: mono- kuni tetra(liitium- ja/või naatrium-)-3-amino-10-[4-(4-amino-3-sulfonatoanilino)-6-[metüül-(2-sulfonatoetüül)amino]-1,3,5-triasiin-2-üülamino]-6-13-diklorobenso[1,2-B:4,5-B']di[1,4]bensoksasiin-4,11-disulfonaat; mono- kuni tetra(liitium- ja/või naatrium)-3-amino-10-[4,6-bis(4-amino-3-sulfonatoanilino)-1,3,5-triasiin-2-üülamino]-6-13-diklorobenso[1,2-B:4,5-B']di[1,4]bensoksasiin-4,11-disulfonaat; mono- kuni penta(liitium- ja/või naatrium)-10,10´-diamino-6,6',13,13´-tetrakloro-3,3'-[6-[metüül-(2-sulfonatoetüül)amino]-1,3,5-triasiin-2,4-diüüldiimino]bis[benso[1,2-B:4,5-B']di[1,4]bensoksasiin-4,11-disulfonaat; mono- kuni hepta(liitium- ja/või naatrium)-10-amino-6,6',13,13'-tetrakloro-10´[4-(4-amino-3-sulfonatoanilino)-[6-metüül-(2-sulfonatoetüül)amino]-1,3,5-triasiin-2,4-diimino]bis[benso[1,2-B:4,5-B']di[1,4]bensoksasiin-4,11-disulfonaat; mono- kuni hepta(liitium- ja/või naatrium)-10,10´-diamino-6,6',3,3'[(2-sulfonato)-1,4-fenüleendiiminobis[6-metüül-(2-sulfonatoetüül)amino]-1,3,5-triasiin-2,4-diüüldiimino]bis[benso[1,2-B:4,5-B']di[1,4]bensoksasiin-4,11-disulfonaat (et)
C&L Inventory
Maisījums no mono līdz tetra(litija un/vai nātrija)3-amino-10-[4-(4-amino-3-sulfonātanilino)-6-[metil-(2-sulfonatoetil)amino]-1,3,5-triazīn-2-ilamino]-6-13-dihlorbenzo[1,2-B:4,5-B']di[1,4]benzoksazīn-4,11-disulfonāta; mono līdz tetra(litija un/vai nātrija)3-amino-10-[4,6-bis(4-amino-3-sulfonātanilino)-1,3,5-triazīn-2-ilamino]-6-13-dihlorbenzo[1,2-B:4,5-B']di[1,4]benzoksazīn-4,11-disulfonāta; mono līdz tetra(litija un/vai nātrija)10,10´-diamino-6,6',13,13´-tetrahlor-3,3'-[6-[metil-(2-sulfonātetil)amino]-1,3,5-triazīn-2,4-diildiimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoksazīn-4,11-disulfonāta; mono līdz tetra(litija un/vai nātrija)10-amino-6,6',13,13'-tetrahlor-10´[4-(4-amino-3-sulfonātanilino)-[6-metil-(2-sulfonātetil)amino]-1,3,5-triazīn-2,4-diildiimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoksazīn-4,11-disulfonāta; mono līdz tetra(litija un/vai nātrija)10,10,10´-diamino-6,6'0,3,3[(2-sulfonāt)-1,4-fenilēndiiminobis[6-metil-(2-sulfonātetil)amino]-1,3,5-triazīn-2,4-diildiimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoksazīn-4,11-disulfonāta (lv)
C&L Inventory
masse de réaction de 3-amino-10-[4-(4-amino-3-sulfonatoanilino)-6-[méthyl-(2-sulfonatoéthyl)amino]-1,3,5-triazin-2-ylamino]-6-13-dichlorobenzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate de mono à tétra(lithium et/ou sodium); 3-amino-10-[4,6-bis(4-amino-3-sulfonatoanilino)-1,3,5-triazin-2-ylamino]-6-13-dichlorobenzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate de mono à tétra(lithium et/ou sodium); 10,10'-diamino-6,6',13,13'-tétrachloro-3,3'-[6-[méthyl-(2-sulfonatoéthyl)amino]-1,3,5-triazin-2,4-diyldiimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate de mono à penta(lithium et/ou sodium); 10-amino-6,6',13,13'-tétrachloro-10'[4-(4-amino-3-sulfonatoanilino)-[6-méthyl-(2-sulfonatoéthyl)amino]-1,3,5-triazin-2,4-diimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate de mono à hepta(lithium et/ou sodium); 10,10'-diamino-6,6',3,3'[(2-sulfonato)-1,4-phénylènediiminobis[6-méthyl-(2-sulfonatoéthyl)amino]-1,3,5-triazin-2,4-diyldiimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate de mono à hepta(lithium et/ou sodium) (fr)
C&L Inventory
Mengsel van mono- tot tetra(lithium en/of natrium)-3-amino-10-[4-(4-amino-3-sulfonatoanilino)-6-[methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2-ylamino]-6,13-dichloorbenzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonaat; mono- tot tetra(lithium en/of natrium)-3-amino-10-[4,6-bis(4-amino-3-sulfonatoanilino)-1,3,5-triazin-2-ylamino]-6,13-dichloorbenzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonaat; mono- tot penta(lithium en/of natrium)-10,10´-diamino-6,6',13,13´-tetrachloor-3,3'-[6-[methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2,4-diyldiimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonaat; mono- tot hepta(lithium en/of natrium)-10-amino-6,6',13,13'-tetrachloor-10´[4-(4-amino-3-sulfonatoanilino)-[6-methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2,4-diimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonaat; mono- tot hepta(lithium en/of natrium)-10,10'-diamino-6,6',3,3'[(2-sulfonato)-1,4-fenyleendiiminobis[6-methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2,4-diyldiimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonaat (nl)
C&L Inventory
mezcla de 3-amino-10-[4-(4-amino-3-sulfonatoanilino)-6-[metil-(2-sulfonatoetil)amino]-1,3,5-triazin-2-ilamino]-6,13-diclorobenzo[1,2-B:4,5-B']di[1,4]benzoxazina-4,11-disulfonato de mono a tetra(litio y/o sodio); 3-amino-10-[4,6-bis(4-amino-3-sulfonatoanilino)-1,3,5-triazin-2-ilamino]-6,13-diclorobenzo[1,2-B:4,5-B']di[1,4]benzoxazina-4,11-disulfonato de mono a tetra(litio y/o sodio); 10,10'-diamino-6,6',13,13'-tetracloro-3,3'-[6-[metil-(2-sulfonatoetil)amino]-1,3,5-triazin-2,4-diildiimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazina-4,11-disulfonato de mono a penta(litio y/o sodio); 10-amino-6,6',13,13'-tetracloro-10´[4-(4-amino-3-sulfonatoanilino)-[6-[metil-(2-sulfonatoetil)amino]-1,3,5-triazin-2,4-diimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazina-4,11-disulfonato de mono a hepta(litio y/o sodio); 10,10'-diamino-6,6',3,3'[(2-sulfonato)-1,4-fenilendiiminobis[6-[metil-(2-sulfonatoetil)amino]-1,3,5-triazin-2,4-diildiimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazina-4,11-disulfonato de mono a hepta(litio y/o sodio) (es)
C&L Inventory
Mieszanina poreakcyjna związków: od mono do tetra(litu i/lub sodu) 3-amino-10-[4-(4-amino-3-sulfonianoanilino)-6-[metylo-(2-sulfonianoetylo)amino]-1,3,5-triazyn-2-ylamino]-6-13-dichlorobenzo[1,2-B:4,5-B']di[1,4]benzoksazyno-4,11-disulfonian; od mono do tetra(litu i/lub sodu) 3-amino-10-[4,6-bis(4-amino-3-sulfonianoanilino)-1,3,5-triazyn-2-ylamino]-6-13-dichlorobenzo[1,2-B:4,5-B']di[1,4]benzoksazyno-4,11-disulfonian; od mono do penta(litu i/lub sodu)10,10´-diamino-6,6',13,13´-tetrachloro-3,3'-[6-[metylo-(2-sulfonianoetylo)amino]-1,3,5-triazyn-2,4-diyldiimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoksazyno-4,11-disulfonian; od mono do hepta(litu i/lub sodu)10-amino-6,6',13,13'-tetrachloro-10´[4-(4-amino-3-sulfonianoanilino)-[6-metylo-(2-sulfonianoetylo)amino]-1,3,5-triazyn-2,4-diimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoksazyno-4,11-disulfonian; od mono do hepta(litu i/lub sodu) 10,10'-diamino-6,6',3,3'[(2-sulfoniano)-1,4-fenylenodiiminobis[6-metylo-(2-sulfonianoetylo)amino]-1,3,5-triazyn-2,4-diyldiimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoksazyno-4,11-disulfonian (pl)
C&L Inventory
miscela di: 3-ammino-10-[4-(4-ammino-3-solfonatoanilino)-6-[metil(2-solfonatoetil)ammino]-1,3,5-triazin-2-ilammino]-6,13-diclorobenzo[1,2-b:4,5-b']di[1,4]benzoxazina-4,11-disolfonato da mono a tetra (litio e/o sodio) (it)
C&L Inventory
Mistura de 3-amino-10-[4-(4-amino-3-sulfonatoanilino)-6-[metil(2-sulfonatoetil)amino]-1,3,5-triazin-2-ilamino]-6,13-diclorobenzo[1,2-b:4,5-b']di[1,4]benzoxazina-4,11-dissulfonato de mono a tetra(lítio e/ou sódio); 3-amino-10-[4,6-bis(4-amino-3-sulfonatoanilino)-1,3,5-triazin-2-ilamino]-6,13-diclorobenzo[1,2-b:4,5-b']di[1,4]benzoxazina-4,11-dissulfonato de mono a tetra(lítio e/ou sódio); 10,10´-diamino-6,6',13,13´-tetracloro-3,3'-[6-[metil(2-sulfonatoetil)amino]-1,3,5-triazina-2,4-diildiimino]bis[benzo[1,2-b:4,5-b']di[1,4]benzoxazina-4,11-dissulfonato de mono a penta(lítio e/ou sódio); 10-amino-6,6',13,13'-tetracloro-10´-[4-(4-amino-3-sulfonatoanilino)-[6-metil(2-sulfonatoetil)amino]-1,3,5-triazina-2,4-diimino]bis[benzo[1,2-b:4,5-b']di[1,4]benzoxazina-4,11-dissulfonato de mono a hepta(lítio e/ou sódio); 10,10'-diamino-6,6',3,3'-[(2-sulfonato)-1,4-fenilenodiiminobis[6-metil(2-sulfonatoetil)amino]-1,3,5-triazina-2,4-diildiimino]bis[benzo[1,2-b:4,5-b']di[1,4]benzoxazina-4,11-dissulfonato de mono a hepta(lítio e/ou sódio) (pt)
C&L Inventory
mišinys: nuo mono iki tetra(ličio ir/arba natrio)3-amino-10-[4-(4-amino-3-sulfonatoanilino)-6-[metil-(2-sulfonatoetil)amino]-1,3,5-triazin-2-ilamino]-6-13-dichlorbenz[1,2-B:4,5-B']di[1,4]benzoksazin-4,11-disulfonato; nuo mono iki tetra(ličio ir/arba natrio)3-amino-10-[4,6-bis(4-amino-3-sulfonatoanilino)-1,3,5-triazin-2-ilamino]-6-13-dichlorbenz[1,2-B:4,5-B']di[1,4]benzoksazin-4,11-disulfonato; nuo mono iki penta(ličio ir/arba natrio)10,10´-diamino-6,6',13,13´-tetrachlor-3,3'-[6-[metil-(2-sulfonatoetil)amino]-1,3,5-triazin-2,4-diildiimino]bis[benz[1,2-B:4,5-B']di[1,4]benzoksazin-4,11-disulfonato; nuo mono iki hepta(ličio ir/arba natrio)10-amino-6,6',13,13'-tetrachlor-10´[4-(4-amino-3-sulfonatoanilino)-[6-metil-(2-sulfonatoetil)amino]-1,3,5-triazin-2,4-diimino]bis[benz[1,2-B:4,5-B']di[1,4]benzoksazin-4,11-disulfonato; nuo mono iki hepta(ličio ir/arba natrio)10,10'-diamino-6,6',3,3'[(2-sulfonato)-1,4-fenilendiiminobis[6-metil-(2-sulfonatoetil)amino]-1,3,5-triazin-2,4-diildiimino]bis[benz[1,2-B:4,5-B']di[1,4]benzoksazin-4,11-disulfonato (lt)
C&L Inventory
mono do hepta(litijev i/ili natrijev)10,10'-diamino- (hr)
C&L Inventory
mono do hepta(litijev i/ili natrijev)10-amino-6,6',13,13'-tetrakloro-10'[4-(4-amino-3-sulfonatoanilino)-[6-metil-(2-sulfonatoetil) (hr)
C&L Inventory
mono do penta(litijev i/ili natrijev)10,10'-diamino- (hr)
C&L Inventory
mono do tetra(litijev i/ili natrijev)3-amino-10-[4,6-bis(4-amino-3-sulfonatoanilino)-1,3,5-triazin-2-ilamino]-6-13-diklorobenzo[1,2-B:4,5-B']di (hr)
C&L Inventory
mono til hepta(litium og/eller natrium)-10,10'-diamino-6,6',3,3'[(2-sulfonato)-1,4-fenylendiiminobis[6-metyl-(2-sulfonatoetyl)amino]-1,3,5-triazin-2,4-diyldiimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoksazin-4,11-disulfonat (no)
C&L Inventory
mono til hepta(litium og/eller natrium)-10-amino-6,6',13,13'-tetraklor-10´[4-(4-amino-3-sulfonatoanilino)-[6-metyl-(2-sulfonatoetyl)amino]-1,3,5-triazin-2,4-diimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoksazin-4,11-disulfonat (no)
C&L Inventory
mono til penta(litium og/eller natrium)-10,10´-diamino-6,6',13,13´-tetraklor-3,3'-[6-[metyl-(2-sulfonatoetyl)amino]-1,3,5-triazin-2,4-diyldiimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoksazin-4,11-disulfonat (no)
C&L Inventory
mono til tetra(litium og/eller natrium)-3-amino-10-[4,6-bis(4-amino-3-sulfonatoanilino)-1,3,5-triazin-2-ylamino]-6-13-diklorbenzo[1,2-B:4,5-B']di[1,4]benzoksazin-4,11-disulfonat (no)
C&L Inventory
mono- til hepta(lithium og/eller natrium)-10,10'-diamino-6,6',3,3'[(2-sulfonato)-1,4-phenylendiiminobis[6-methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2,4-diyldiimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazin-4,11-disulfonat (da)
C&L Inventory
mono- til hepta(lithium og/eller natrium)-10-amino-6,6',13,13'-tetrachlor-10´[4-(4-amino-3-sulfonatoanilino)-[6-methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2,4-diimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazin-4,11-disulfonat og (da)
C&L Inventory
mono- til penta(lithium og/eller natrium)-10,10´-diamino-6,6',13,13´-tetrachlor-3,3'-[6-[methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2,4-diyldiimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazin-4,11-disulfonat (da)
C&L Inventory
mono- til tetra(lithium og/eller natrium)-3-amino-10-[4,6-bis(4-amino-3-sulfonatoanilino)-1,3,5-triazin-2-ylamino]-6,13-dichlorbenzo[1,2-B:4,5-B']di[1,4]benzoxazin-4,11-disulfonat (da)
C&L Inventory
mono- til tetra(lithium og/eller natrium)-3-amino-10-[4-(4-amino-3-sulfonatoanilino)-6-[methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2-ylamino]-6,13-dichlorbenzo[1,2-B:4,5-B']di[1,4]benzoxazin-4,11-disulfonat (da)
C&L Inventory
mono-, di-, tri- és tetra(lítium és/vagy nátrium)3-amino-10-[4-(4-amino-3-szulfonatoanilino)-6-[metil-(2-szulfonatoetil)amino]-1,3,5-triazin-2-il-amino]-6-13-diklórbenzo[1,2-B:4,5-B']di[1,4]benzoxazin-4,11-diszulfonát; mono-, di-, tri- és tetra(lítium és vagy nátrium)3-amino-10-[4,6-bisz(4-amino-3-szulfonatoanilino)-1,3,5-triazin-2-il-amino]-6-13-diklórbenzo[1,2-B:4,5-B']di[1,4]benzoxazin-4,11-diszulfonát; mono-, di-, tri-, tetra- és penta(lítium és/vagy nátrium)10,10´-diamino-6,6',13,13´-tetraklór-3,3'-[6-[metil-(2-szulfonatoetil)amino]-1,3,5-triazin-2,4-diil-diimino]bisz[benzo[1,2-B:4,5-B']di[1,4]benzoxazin-4,11-diszulfonát; mono-, di-, tri-, tetra-, penta-, hexa- és hepta(lítium és/vagy nátrium)10-amino-6,6',13,13'-tetraklór-10´[4-(4-amino-3-szulfonatoanilino)-[6-metil-(2-szulfonatoetil)amino]-1,3,5-triazin-2,4-diimino]bisz[benzo[1,2-B:4,5-B']di[1,4]benzoxazin-4,11-diszulfonát; mono-, di-, tri-, tetra-, penta-, hexa- és hepta(lítium és/vagy nátrium)10,10'-diamino-6,6',3,3'[(2-szulfonato)-1,4-fenilén-diiminobisz[6-metil-(2-szulfonatoetil)amino]-1,3,5-triazin-2,4-diil-diimino]bisz[benzo[1,2-B:4,5-B']di[1,4]benzoxazin-4,11-diszulfonát keveréke (hu)
C&L Inventory
Reaction mass von Mono- bis Tetra(lithium und/oder -natrium)3-amino-10-[4-(4-amino-3-sulfonatanilin)-6-[methyl-(2-sulfonatethyl)amino]-1,3,5-triazin-2-ylamino]-6-13-dichlorbenzo[1,2-B:4,5-B']di[1,4]benzoxazin-4,11-disulfonat; Mono- bis Tetra(lithium und/oder -natrium)3-amino-10-[4,6-bis(4-amino-3-sulfonatanilin)-1,3,5-triazin-2-ylamino]-6-13-dichlorbenzo[1,2-B:4,5-B']di[1,4]benzoxazin-4,11-disulfonat; Mono- bis Penta(lithium und/oder -natrium)10,10´-diamino-6,6',13,13´-tetrachlor-3,3'-[6-[methyl-(2-sulfonatethyl)amino]-1,3,5-triazin-2,4-diyldiimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazin-4,11-disulfonat; Mono- bis Hepta(lithium und/oder -natrium)10-amino-6,6',13,13'-tetrachlor-10´[4-(4-amino-3-sulfonatanilino)-[6-methyl-(2-sulfonatethyl)amino]-1,3,5-triazin-2,4-diimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazin-4,11-disulfonat; Mono- bis Hepta(lithium und/oder -natrium)10,10'-diamino-6,6',3,3'[(2-sulfonat)-1,4-phenylendiiminobis[6-methyl-(2-sulfonatethyl)amino]-1,3,5-triazin-2,4-diyldiimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazin-4,11-disulfonat (de)
C&L Inventory
reakcijska smjesa mono do tetra(litijev i/ili natrijev)3-amino-10-[4-(4-amino-3-sulfonatoanilino)-6- (hr)
C&L Inventory
reakčná zmes zložená z týchto látok: mono- až tetra(lítium a/alebo nátrium)-3-amino-10-{4-(4-amino-3-sulfonátoanilino)-6-[metyl(2-sulfonátoetyl)amino]-1,3,5-triazín-2-ylamino}-6,13-dichlórbenzo[1,2-b:4,5-b']di[1,4]benzoxazín-4,11-disulfonát; mono- až tetra(lítium a/alebo nátrium)-3-amino-10-[4,6-bis(4-amino-3-sulfonátoanilino)-1,3,5-triazín-2-ylamino]-6,13-dichlórbenzo[1,2-b:4,5-b']di[1,4]benzoxazín-4,11-disulfonát; mono- až penta(lítium a/alebo nátrium)-10,10´-diamino-6,6',13,13´-tetrachlór-3,3'-[6-[metyl(2-sulfonátoetyl)amino]-1,3,5-triazín-2,4-diylbis(imino)]bis(benzo[1,2-b:4,5-b']di[1,4]benzoxazín-4,11-disulfonát); mono- až hepta(lítium a/alebo nátrium)-10-amino-6,6',13,13'-tetrachlór-10´-[4-(4-amino-3-sulfonátoanilino)-[6-metyl-(2-sulfonátoetyl)amino]-1,3,5-triazín-2,4-diylbis(imino)]bis(benzo[1,2-b:4,5-b']di[1,4]benzoxazín-4,11-disulfonát); mono- až hepta(lítium a/alebo nátrium)-10,10'-diamino-6,6',3,3'-[(2-sulfonáto)-1,4-fenyléndiiminobis[6-metyl-(2-sulfonátoetyl)amino]-1,3,5-triazín-2,4-diyldiimino]bis[benzo[1,2-b:4,5-b']di[1,4]benzoxazín-4,11-disulfonát (sk)
C&L Inventory
reakční směs: mono až tetra(lithium a/nebo natrium) - 3- amino- 10- [4- (4- amino- 3- sulfonatoanilino) - 6- [methyl- (2- sulfonatoethyl) amino]- 1,3,5- triazin- 2- ylamino]- 6,13- dichlorbenzo[1,2- b:4,5- b']di [1,4]benzoxazin- 4,11- disulfonátu; mono až tetra(lithium a/ nebo natrium) 3- amino- 10- [4,6- bis(4- amino- 3- sulfonatoanilino) - 1,3,5- triazin- 2- ylamino]- 6,13- dichlorbenzo[1,2- b:4,5- b']di[1,4] benzoxazin- 4,11- disulfonátu; Mono až penta(lithium a/nebo natrium) - 10,10'diamino- 6,6',13,13'- tetrachlor- 3,3'- [6- [methyl- (2- sulfonatoethyl) amino]- 1,3,5- triazin- 2,4- diyldiimino]bis[benzo[1,2- b:4,5- b']di[1,4]benzoxazin- 4,11- disulfonátu; mono až hepta(lithium a/nebo natrium) - 10- amino- 6,6',13,13'- tetrachlor- 10'[4- (4- amino- 3- sulfonatoanilino) - [6- methyl- (2- sulfonatoethyl) amino]- 1,3,5- triazin- 2,4- diimino]bis[benzo[1,2- b:4,5- b']di[1,4]benzoxazin- 4,11- disulfonátu; Mono až hepta(lithium a/nebo natrium) - 10,10'- diamino- 6,6',3,3'[(2- sulfonato) - 1,4- fenylendiiminobis[6- methyl- (2- sulfonatoethyl) amino]- 1,3,5- triazin- 2,4- diyldiimino]bis [benzo[1,2- b:4,5- b']di[1,4]benzoxazin- 4,11- disulfonátu (cs)
C&L Inventory
seos: mono–tetra(litium ja/tai natrium)3-amino-10-[4-(4-amino-3-sulfonaattianiliini)-6-[ metyyli-(2-sulfonaattietyyli)amino]-1,3,5- triatsin-2-yylilamino]-6-13-diklooribentso[1,2-B:4,5-B']di[1,4]bentsoksatsiini-4,11- disulfonaatti; mono–tetra(litium ja/tai natrium)3-amino-10-[4,6-bis(4-amino-3-sulfonaattianiliini)-1,3,5-triatsin-2-yyliamino]-6-13-diklooribentso[1,2-B:4,5-B']di[1,4]bentsoksatsiini-4,11- disulfonaatti; mono–penta(litium ja/tai natrium)10,10´-diamino-6,6',13,13´-tetrakloori-3,3'-[6- [metyyli-(2-sulfonaattietyyli)amino]-1,3,5-triatsiini-2,4- diyyli-di-imino]bis[bentso[1,2-B:4,5-B']di[1,4] bentsoksatsiini-4,11- disulfonaatti; mono–hepta(litium ja/tai natrium)10,10´-diamino-6,6',3,3´[(2-sulfonaatti)-1,4-fenyleenidi-iminobis[6-metyyli-2-sulfonaattietyyli)amino]-1,3,5-triatsiini-2,4-diyyli-di-imino]bis[bentso[1,2-B:4,5-B']di[1,4]bentsoksatsiini-4,11- disulfonaatti (fi)
C&L Inventory
Taħlita ta’ mono sa tetra(litju u/jew sodju)3-amino-10-[4-(4-amino-3-sulfonatoanilino)-6-[methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2-ylamino]-6-13-dichlorobenzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate; mono sa tetra(litju u/jew sodju)3-amino-10-[4,6-bis(4-amino-3-sulfonatoanilino)-1,3,5-triazin-2-ylamino]-6-13-dichlorobenzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate; mono sa penta(litju u/jew sodju)10,10´-diamino-6,6',13,13´-tetrachloro-3,3'-[6-[methyl-(2-sulfaonatoethyl)amino]-1,3,5-triazin-2,4-diyldiimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate; mono sa epta(litju u/jew sodju)10-amino-6,6',13,13'-tetrachloro-10´[4-(4-amino-3-sulfonatoanilino)-[6-methyl-(2-sulfonatoethl)amino]-1,3,5-triazin-2,4-diimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate; mono sa hepta(litju u/jew sodju)10,10'-diamino-6,6',3,3'[(2-sulfonato)-1,4-phenylenediiminobis[6-methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2,4-diyldiimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate (mt)
C&L Inventory
zmes mono do tetra(litijevega in/ali natrijevega)3-amino-10-[4-(4-amino-3-sulfonatoanilino)-6-[metil-(2-sulfonatoetil)amino]-1,3,5-triazin-2-ilamino]-6-13-diklorobenzo[1,2-B:4,5-B']di[1,4]benzoksazin-4,11-disulfonata; mono do tetra(litijevega in/ali natrijevega)3-amino-10-[4,6-bis(4-amino-3-sulfonatoanilino)-1,3,5-triazin-2-ilamino]-6-13-diklorobenzo[1,2-B:4,5-B']di[1,4]benzoksazin-4,11-disulfonata; mono do penta(litijevega in/ali natrijevega)10,10´-diamino-6,6',13,13´-tetrakloro-3,3'-[6-[metil-(2-sulfonatoetil)amino]-1,3,5-triazin-2,4-diildiimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoksazin-4,11-disulfonata; mono do hepta(litijevega in/ali natrijevega)10-amino-6,6',13,13´-tetrakloro-10'[4-(4-amino-3-sulfonatoanilino)-[6-metil-(2-sulfonatoetil)amino]-1,3,5-triazin-2,4-diimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoksazin-4,11-disulfonata; mono do hepta(litijevega in/ali natrijevega)10,10'-diamino-6,6',3,3[(2-sulfonato)-1,4-fenilendiiminobis[6-metil-(2-sulfonatoetil)amino]-1,3,5-triazin-2,4-diildiimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoksazin-4,11-disulfonata (sl)
C&L Inventory
Μίγμα από 3-αμινο-10-[4-(4-αμινο-3-σουλφοανιλινο)-6-[μεθυλο-(2-σουλφοαιθυλ)αμινο]-1,3,5-τριαζιν-2-υλαμινο]-6-13-διχλωροβενζο[1,2-β:4,5-β']δι[1,4]βενζοξαζινο-4,11-δισουλφονικό μονο έως τετρα(λίθιο ή/και νάτριο), 3-αμινο-10-[4,6-δις(4-αμινο-3-σουλφοανιλινο)-1,3,5-τριαζιν-2-υλαμινο]-6-13-διχλωροβενζο[1,2-β:4,5-β']δι[1,4]βενζοξαζινο-4,11-δισουλφονικό μονο έως τετρα(λίθιο ή/και νάτριο), 10,10´-διαμινο-6,6',13,13´-τετραχλωρο-3,3'-[6-[μεθυλο-(2-σουλφοαιθυλ)αμινο]-1,3,5-τριαζινο-2,4-διυλοδιιμινο]δις[βενζο[1,2-β:4,5-β']δι[1,4]βενζοξαζινο-4,11-δισουλφονικό μονο έως πεντα(λίθιο ή/και νάτριο), 10-αμινο-6,6',13,13'-τετραχλωρο-10´[4-(4-αμινο-3-σουλφοανιλινο)6-[μεθυλο-(2-σουλφοαιθυλ)αμινο]-1,3,5-τριαζινο-2,4-διιμινο]δις[βενζο[1,2-β:4,5-β']δι[1,4]βενζοξαζινο-4,11-δισουλφονικό μονο έως επτα(λίθιο ή/και νάτριο) και 10,10´-διαμινο-6,6',3,3´[(2-σουλφο)-1,4-φαινυλενοδιιμινοδις[6-μεθυλο-(2-σουλφοαιθυλ)αμινο]-1,3,5-τριαζινο-2,4-διυλοδιιμινο]δις[βενζο[1,2-β:4,5-β']δι[1,4]βενζοξαζινο-4,11-δισουλφονικό μονο έως επτα(λίθιο ή/και νάτριο) (el)
C&L Inventory
реакционна маса от моно до тетра(литиев и/или натриев)3-амино-10-[4-(4-амино-3-сулфонатоанилино)-6-[метил-(2-сулфонатоетил)амино]-1,3,5-триазин-2-иламино]-6-13-дихлоробензо[1,2-B:4,5-B']ди[1,4]бензоксазинe-4,11-дисулфонат; моно до тетра (литиев и/или натриев)3-амино-10-[4,6-бис(4-амино-3-сулфонатоанилино)-1,3,5-триазин-2-иламино]-6-13-дихлоробензо[1,2-B:4,5-B']ди[1,4] бензоксазин-4,11-дисулфонат; моно до пента (литиев и/или натриев)10,10´-диамино-6,6',13,13´-тетрахлоро-3,3'-[6-[метил-(2-сулфонатоетил)амино]-1,3,5-триазин-2,4-диилдиимино]бис[бензо[1,2-B:4,5-B']ди[1,4]бензоксазин-4,11-дисулфонат; моно до хепта(литиев и/или натриев)10-амино-6,6',13,13'-тетрахлоро-10´[4-(4-амино-3-сулфонатоанилино)-[6-метил-(2-сулфонатоетил)амино]-1,3,5-триазин-2,4-диимино]бис[бензо[1,2-B:4,5-B']ди[1,4] бензоксазин-4,11-дисулфонат; моно до хепта (литиев и/или натриев)10,10'-диамино-6,6',3,3'[(2-сулфонато)-1,4-фенилендииминобис[6-метил-(2-сулфонатоетил)амино]-1,3,5-триазин-2,4-диилдиимино]бис[бензо[1,2-B:4,5-B']ди[1,4] бензоксазин-4,11-дисулфонат (bg)
C&L Inventory
reaction mass of mono to tetra(lithium and/or sodium)3-amino-10-[4-(4-amino-3-sulfonatoanilino)-6-[methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2-ylamino]-6-13-dichlorobenzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonatemono to tetra(lithium and/or sodium)3-amino-10-[4,6-bis(4-amino-3-sulfonatoanilino)-1,3,5-triazin-2-ylamino]-6-13-dichlorobenzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonatemono to penta(lithium and/or sodium)10,10'-diamino-6,6',13,1''-tetrachloro-3,3'-[6-[methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2,4-diyldiimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonatemono to hepta(lithium and/or sodium)10-amino-6,6',13,13'-tetrachloro-10'[4-(4-amino-3-sulfonatoanilino)-[6-methyl-(2-sulfonatoethl)amino]-1,3,5-triazin-2,4-diimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonatemono to hepta(lithium and/or sodium)10,10'-diamino-6,6',3,3'[(2-sulfonato)-1,4-phenylenediiminobis[6-methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2,4-diyldiimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate
Registration dossier
Reaction mass of mono to tetra(lithium and/or sodium)3-amino-10-[4-(4-amino-3-sulfonatoanilino)-6-[methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2-ylamino]-6-13-dichlorobenzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonatemono to tetra(lithium and/or sodium)3-amino-10-[4,6-bis(4-amino-3-sulfonatoanilino)-1,3,5-triazin-2-ylamino]-6-13-dichlorobenzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonatemono to penta(lithium and/or sodium)10,10'-diamino-6,6',13,1''-tetrachloro-3,3'-[6-[methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2,4-diyldiimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonatemono to hepta(lithium and/or sodium)10-amino-6,6',13,13'-tetrachloro-10'[4-(4-amino-3-sulfonatoanilino)-[6-methyl-(2-sulfonatoethl)amino]-1,3,5-triazin-2,4-diimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonatemono to hepta(lithium and/or sodium)10,10'-diamino-6,6',3,3'[(2-sulfonato)-1,4-phenylenediiminobis[6-methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2,4-diyldiimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate.
C&L Inventory
tridecalithium(1+) tetradecasodium 3-({4-[(4-amino-3-sulfophenyl)amino]-6-[methyl(2-sulfoethyl)amino]-1,3,5-triazin-2-yl}amino)-10-({4-[(10-amino-6,13-dichloro-4,11-disulfo-5,12-dioxa-7,14-diazapentacen-3-yl)amino]-6-[methyl(2-sulfoethyl)amino]-1,3,5-triazin-2-yl}amino)-6,13-dichloro-5,12-dioxa-7,14-diazapentacene-4,11-disulfonate 3-amino-10-({4,6-bis[(4-amino-3-sulfophenyl)amino]-1,3,5-triazin-2-yl}amino)-6,13-dichloro-5,12-dioxa-7,14-diazapentacene-4,11-disulfonate 3-amino-10-({4-[(10-amino-6,13-dichloro-4,11-disulfo-5,12-dioxa-7,14-diazapentacen-3-yl)amino]-6-[methyl(2-sulfoethyl)amino]-1,3,5-triazin-2-yl}amino)-6,13-dichloro-5,12-dioxa-7,14-diazapentacene-4,11-disulfonate 3-amino-10-({4-[(4-amino-3-sulfophenyl)amino]-6-[methyl(2-sulfoethyl)amino]-1,3,5-triazin-2-yl}amino)-6,13-dichloro-5,12-dioxa-7,14-diazapentacene-4,11-disulfonate 3-amino-10-[(4-{[4-({4-[(10-amino-6,13-dichloro-4,11-disulfo-5,12-dioxa-7,14-diazapentacen-3-yl)amino]-6-[methyl(2-sulfoethyl)amino]-1,3,5-triazin-2-yl}amino)-2-sulfophenyl]amino}-6-[methyl(2-sulfoethyl)amino]-1,3,5-triazin-2-yl)amino]-6,13-dichloro-5,12-dioxa-7,14-diazapentacene-4,11-disulfonate
Other
607-523-00-9
Index number
C&L Inventory

Scientific properties

Physical and chemical properties

This section provides physicochemical information compiled from all automatically processable data from REACH registration dossiers that is available to ECHA at the time of generation. The quality and correctness of the information remains the responsibility of the data submitter. The Agency thus cannot guarantee the correctness of the information displayed.

Appearance/physical state / colour

Study results
  • 3 studies submitted
  • 1 study processed
C Physical state at 20°C and 1013 hPa
Solid (100%) [1]
C Form
Other (100%) [1]

Type of Study provided
Studies with data
Key study 1
Supporting study
Weight of evidence
Other 2
Data waiving
no waivers
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Melting/freezing point

Study results
  • 3 studies submitted
  • 1 study processed
R Melting / freezing point
400 °C [1]

Type of Study provided
Studies with data
Key study 1
Supporting study
Weight of evidence
Other 2
Data waiving
no waivers
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Boiling point

Study results
  • 3 studies submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study
Supporting study
Weight of evidence
Other 2
Data waiving
Not feasible
Sci. unjustified 1
Exposure cons.
Other
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Density

Study results
  • 3 studies submitted
  • 1 study processed
R Relative density
1.64 @ 20 °C [1]

Type of Study provided
Studies with data
Key study 1
Supporting study
Weight of evidence
Other 2
Data waiving
no waivers
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Vapour pressure

Study results
  • 3 studies submitted
  • 1 study processed
R Vapour pressure
0 Pa @ 25 °C [1]

Type of Study provided
Studies with data
Key study 1
Supporting study
Weight of evidence
Other 2
Data waiving
no waivers
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Partition coefficient

Study results
  • 3 studies submitted
  • 1 study processed
R Log Pow
-4.4 @ 20 °C [1]

Type of Study provided
Studies with data
Key study 1
Supporting study
Weight of evidence
Other 2
Data waiving
no waivers
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Water solubility

Study results
  • 3 studies submitted
  • 1 study processed
R Water solubility (mass/vol.)
300 g/L @ 20 °C [1]

Type of Study provided
Studies with data
Key study 1
Supporting study
Weight of evidence
Other 2
Data waiving
no waivers
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Solubility in organic solvents / fat solubility

Data not provided by the registrant

Surface tension

Study results
  • 3 studies submitted
  • 1 study processed
R Surface tension
66 mN/m @ 1 g/L and 20 °C [1]

Type of Study provided
Studies with data
Key study 1
Supporting study
Weight of evidence
Other 2
Data waiving
no waivers
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Flash point

Study results
  • 3 studies submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study
Supporting study
Weight of evidence
Other 2
Data waiving
Not feasible 1
Sci. unjustified
Exposure cons.
Other
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Auto flammability

Study results
  • 3 studies submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study 1
Supporting study
Weight of evidence
Other 2
Data waiving
no waivers
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Flammability

Study results
  • 3 studies submitted
  • 1 study processed
C Interpretation of results
Non flammable (100%) [1]

Type of Study provided
Studies with data
Key study 1
Supporting study
Weight of evidence
Other 2
Data waiving
no waivers
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Explosiveness

Study results
  • 3 studies submitted
  • 1 study processed
C Interpretation of results
Non-explosive (100%) [1]

Type of Study provided
Studies with data
Key study 1
Supporting study
Weight of evidence
Other 2
Data waiving
no waivers
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Oxidising

Study results
  • 3 studies submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study
Supporting study
Weight of evidence
Other 2
Data waiving
Not feasible
Sci. unjustified 1
Exposure cons.
Other
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Oxidation reduction potential

Data not provided by the registrant

pH

Data not provided by the registrant

Dissociation constant

Data not provided by the registrant

Viscosity

Data not provided by the registrant

Environmental fate and pathways

This section provides environmental fate and pathways information compiled from all automatically processable data from REACH registration dossiers that is available to ECHA at the time of generation. The quality and correctness of the information remains the responsibility of the data submitter. The Agency thus cannot guarantee the correctness of the information displayed.

Phototransformation in air

Data not provided by the registrant

Hydrolysis

Study results
  • 3 studies submitted
  • 0 studies processed

Study data not processed for brief profile

Type of Study provided
Studies with data
Key study 1
Supporting study
Weight of evidence
Other 2
Data waiving
no waivers
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Phototransformation in water

Data not provided by the registrant

Phototransformation in soil

Data not provided by the registrant

Biodegradation in water - screening tests

Study results
  • 6 studies submitted
  • 2 studies processed
C Interpretation of results
Not inherently biodegradable (50%), Under test conditions no biodegradation observed (50%) [2]

Type of Study provided
Studies with data
Key study 2
Supporting study
Weight of evidence
Other 4
Data waiving
no waivers
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Biodegradation in water & sediment - simulation tests

Data not provided by the registrant

Biodegradation in soil

Data not provided by the registrant

Bioaccumulation: aquatic / sediment

Data not provided by the registrant

Bioaccumulation: terrestrial

Data not provided by the registrant

Adsorption/desorption

Data not provided by the registrant

Henrys law constant (H)

Data not provided by the registrant

Distribution modelling

Data not provided by the registrant

Ecotoxicological information

This section provides ecotoxicological information compiled from all automatically processable data from REACH registration dossiers that is available to ECHA at the time of generation. The quality and correctness of the information remains the responsibility of the data submitter. The Agency thus cannot guarantee the correctness of the information displayed.

Predicted No-Effect Concentration (PNEC)

Data not provided by the registrant

Short–term toxicity to fish

Study results
  • 3 studies submitted
  • 1 study processed
P/RResults
LC50 (4 days) 100 mg/L [1]
LC0 (4 days) 100 mg/L [1]
LC100 (4 days) 100 mg/L [1]
NOEC (4 days) 100 mg/L [1]

Type of Study provided
Studies with data
Key study 1
Supporting study
Weight of evidence
Other 2
Data waiving
no waivers
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Long–term toxicity to fish

Data not provided by the registrant

Short–term toxicity to aquatic invertebrates

Study results
  • 3 studies submitted
  • 1 study processed
P/RResults
EC50 (48 h) 220 mg/L [1]
EC0 (48 h) 220 mg/L [1]
NOEC (48 h) 220 mg/L [1]

Type of Study provided
Studies with data
Key study 1
Supporting study
Weight of evidence
Other 2
Data waiving
no waivers
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Long–term toxicity to aquatic invertebrates

Data not provided by the registrant

Toxicity to aquatic algae and cyanobacteria

Study results
  • 3 studies submitted
  • 1 study processed
P/RResults
EC50 (72 h) 10.3 - 45 mg/L [2]
NOEC (72 h) 1 mg/L [2]
EC10 (72 h) 1.3 - 3.9 mg/L [2]

Type of Study provided
Studies with data
Key study 1
Supporting study
Weight of evidence
Other 2
Data waiving
no waivers
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Toxicity to aquatic plants other than algae

Data not provided by the registrant

Toxicity to microorganisms

Study results
  • 3 studies submitted
  • 1 study processed
P/RResults
IC50 (3 h) 1 g/L [1]
NOEC (3 h) 1 g/L [1]

Type of Study provided
Studies with data
Key study 1
Supporting study
Weight of evidence
Other 2
Data waiving
no waivers
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Sediment toxicity

Data not provided by the registrant

Endocrine disrupter testing in aquatic vertebrates – in vivo

Data not provided by the registrant

Toxicity to terrestrial macroorganisms except arthropods

Data not provided by the registrant

Toxicity to terrestrial arthropods

Data not provided by the registrant

Toxicity to terrestrial plants

Data not provided by the registrant

Toxicity to soil microorganisms

Data not provided by the registrant

Toxicity to birds

Data not provided by the registrant

Toxicity to mammals

Data not provided by the registrant

Toxicological information

This section provides toxicological information compiled from all automatically processable data from REACH registration dossiers that is available to ECHA at the time of generation. The quality and correctness of the information remains the responsibility of the data submitter. The Agency thus cannot guarantee the correctness of the information displayed.

Derived No- or Minimal Effect Level (DN(M)EL)

Data not provided by the registrant

Toxicokinetics, metabolism, and distribution

Study results
Study data: basic toxicokinetics
  • 2 studies submitted
  • 0 studies processed

Study data not processed for brief profile

Type of Study provided
Study data: basic toxicokinetics
Studies with data
Key study
Supporting study
Weight of evidence
Other 2
Data waiving
no waivers
Study data: dermal absorption
  • 0 studies submitted
  • 0 studies processed

Study data not processed for brief profile

Study data: dermal absorption
Studies with data
Key study
Supporting study
Weight of evidence
Other
Data waiving
no waivers
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Acute toxicity

Study results
oral
  • 3 studies submitted
  • 1 study processed
P/RResults
LD50 2 000 mg/kg bw (rat) [1]
M/CInterpretations of results
Not classified [1]

Type of Study provided
oral
Studies with data
Key study 1
Supporting study
Weight of evidence
Other 2
Data waiving
no waivers
inhalation
  • 0 studies submitted
  • 0 studies processed

No data available

inhalation
Studies with data
Key study
Supporting study
Weight of evidence
Other
Data waiving
no waivers
dermal
  • 3 studies submitted
  • 1 study processed
P/RResults
LD50 2 000 mg/kg bw (rat) [1]
M/CInterpretations of results
Not classified [1]

dermal
Studies with data
Key study 1
Supporting study
Weight of evidence
Other 2
Data waiving
no waivers
other routes
  • 0 studies submitted
  • 0 studies processed

No data available

other routes
Studies with data
Key study
Supporting study
Weight of evidence
Other
Data waiving
no waivers
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Irritation / corrosion

Study results
Study data: skin
  • 4 studies submitted
  • 0 studies processed

Study data not processed for brief profile

Type of Study provided
Study data: skin
Studies with data
Key study 1
Supporting study
Weight of evidence
Other 2
Data waiving
Not feasible
Sci. unjustified 1
Exposure cons.
Other
Study data: eye
  • 4 studies submitted
  • 0 studies processed

Study data not processed for brief profile

Study data: eye
Studies with data
Key study 1
Supporting study
Weight of evidence
Other 2
Data waiving
Not feasible
Sci. unjustified 1
Exposure cons.
Other
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Sensitisation

Study results
Study data: skin
  • 4 studies submitted
  • 0 studies processed

Study data not processed for brief profile

Type of Study provided
Study data: skin
Studies with data
Key study 1
Supporting study
Weight of evidence
Other 2
Data waiving
Not feasible
Sci. unjustified 1
Exposure cons.
Other
Study data: respiratory
  • 0 studies submitted
  • 0 studies processed

Study data not processed for brief profile

Study data: respiratory
Studies with data
Key study
Supporting study
Weight of evidence
Other
Data waiving
no waivers
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Repeated dose toxicity

Study results
Study data: oral
  • 3 studies submitted
  • 1 study processed
P/RResults
NOAEL (rat): 50 mg/kg bw/day [1]
LOAEL (rat): 200 mg/kg bw/day [1]

Type of Study provided
Study data: oral
Studies with data
Key study 1
Supporting study
Weight of evidence
Other 2
Data waiving
no waivers
Study data: inhalation
  • 0 studies submitted
  • 0 studies processed

No data available

Study data: inhalation
Studies with data
Key study
Supporting study
Weight of evidence
Other
Data waiving
no waivers
Study data: dermal
  • 0 studies submitted
  • 0 studies processed

No data available

Study data: dermal
Studies with data
Key study
Supporting study
Weight of evidence
Other
Data waiving
no waivers
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Genetic toxicity

Study results
Study data: in vitro
  • 9 studies submitted
  • 0 studies processed

Study data not processed for brief profile

Type of Study provided
Study data: in vitro
Studies with data
Key study 3
Supporting study
Weight of evidence
Other 6
Data waiving
no waivers
Study data: in vivo
  • 0 studies submitted
  • 0 studies processed

Study data not processed for brief profile

Study data: in vivo
Studies with data
Key study
Supporting study
Weight of evidence
Other
Data waiving
no waivers
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Carcinogenicity

Data not provided by the registrant

Toxicity to reproduction

Data not provided by the registrant

Neurotoxicity

Data not provided by the registrant

Immunotoxicity

Data not provided by the registrant

Endocrine disrupter mammalian screening - in vivo

Data not provided by the registrant